DEL Webinar
About the Live Webinar
| Title: | “Unlocking the Power of DELs Through Novel Encoding Strategies” |
| Date | Time | Duration: | 8th October 2024 | 4 pm CEST | 7am PST | 10am EDT | 30 minutes |
| Speakers | Dr. Thorsten Genski (Serengen), Dr. Anil Argarwal (Taros Chemicals) |
Join us for an insightful webinar on the cutting-edge advancements in DNA-Encoded Libraries (DELs) technology. Discover how Taros’ spin-out company Serengen’s innovative approach is overcoming traditional limitations, enabling unparalleled chemical diversity, and delivering only tractable hits for faster and more cost-effective drug discovery. Learn about the history, advantages, and transformative potential of DELs in modern medicinal chemistry.
This Webinar is a MUST for Biotechs, Pharmas and Research Institutions looking to discover more about Serengen’s breakthrough DNA-Encoded Library (DEL) Technology that eliminates the bottlenecks and major cost drivers of established unbiased screening technologies.
Speaker 1) Dr.Thorsten Genski, CEO Serengen GmbH
Thorsten Genski is the CEO of Serengen GmbH, where he leads efforts to innovate drug discovery using advanced DNA-encoded library (DEL) technology in combination with artificial intelligence. Before taking on this role, Genski built an extensive background in the life sciences and biotech sectors, having held key positions that honed his expertise in scientific research, technology development, and business leadership. He previously worked with companies specializing in biotechnology solutions, where he gained valuable experience in project management and innovation within the pharmaceutical and biotechnology industries. His career trajectory reflects a deep commitment to leveraging new technologies to accelerate the development of therapeutic solutions, with a particular focus on enhancing the precision and efficiency of drug discovery processes. At Serengen, Genski continues to push the boundaries of drug discovery by fostering strategic partnerships and driving the company’s mission to make serendipitous scientific breakthroughs more systematic and accessible.
Speaker 2) Dr. Anil Argarwal – Head of Medicinal Chemistry
Anil is a distinguished medicinal chemist with over 17 years of experience specializing in early drug discovery across various
therapeutic areas including Oncology, Neuroscience, anti-infectives, and metabolic diseases.
A PhD graduate from the University of Leeds, Anil has contributed
significantly to the field, notably as a coinventor of two clinical-stage molecules:
ALK5i – PF 06952229 (Pfizer) and CDK 2,4,6 inhibitor – NUV-422 (Nuvation Bio), both currently in Phase-I trials.
His recent work includes leading over ten drug discovery projects, advancing two clinical candidates, and numerous lead molecules in areas such as oncology and liver disease.
Notably, a molecular glue has been nominated for further development with Anil credited as an inventor. His expertise extends to optimizing lead molecules through structure-activity relationship analysis, greatly enhancing project outcomes and organizational growth.
Any questions before our webinar?
contact us in advance to arrange a personal meeting
Drug Discovery
Custom Synthesis
We support our customers by providing first kg quantities of fine and specialty chemicals, cost reduction of existing syntheses, streamlining chemical processes considering…
